Innovation Hub
/
Webinar
/
When the Barrier to a Breakthrough Drug is You Can't Make It - September 28th

When the Barrier to a Breakthrough Drug is You Can't Make It - September 28th

Watch Now

Date:

September 27, 2022

Time (PT):

1:00 PM

Despite all of their promise, newer medicines, especially those based on advanced technologies, have been met with unprecedented challenges in scaling up manufacturing, quality control and commercial launch.

Hear how developers have approached different aspects of the manufacturing process to bring new and innovative treatments to patients.

Speakers:C. Greg Guyer, Ph.D., chief technical officer and executive vice president of global manufacturing and technical operations, BioMarinSierk Poetting, Ph.D., chief operating officer, BioNTechMatthew Herper, senior writer, editorial director of events, STAT (moderator)

Click here to find additional information and registration details.

Topics

Health Economics & Outcomes Research (HEOR)

Watch Now

Watch On Demand

When the Barrier to a Breakthrough Drug is You Can't Make It - September 28th

Topics

Watch Now

Related Content

Closing Gaps in Care: Health Equity and the Inflation Reduction Act - A Cutting Edge Conversation

Network meta-analysis and its role in evidence-based decision-making

Network meta-analysis and its role in evidence-based decision-making

Addressing Orphan and Rare Diseases - A Cutting Edge Conversation

Joint Clinical Assessment 2025: Pioneering Pathways for Oncology, Advanced Therapies & Rare Diseases

RWE reality check: Routine patient health records and regulatory requirements

"S" Stands for Systematic: Demystifying the Systematic Literature Review

Survival Analysis for Immature Data: A Review of Techniques and Lessons Learned

Market Access - Transforming BioTech Commercial Decisions?

The Scientific and Operational Elegance of Study Replication with Real-World EHR Data: A Vitiligo and Alopecia Example

Insights from the 2024 Salary Survey Report by HealthEconomics.com

Integrated Evidence Generation Planning: Driving Successful Reimbursement and Life Cycle Management

Patient Voices Matter: Transforming Industry-Sponsored Real-World Evidence with Patient-Centric Approaches

Strategies to Optimize Commercialization of Oncology Treatments for Younger Adults

Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters

Cutting Edge Conversations: Value, Access and Evidence - Biotech Market Access

EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025

Bridging the Gap: Strategies for Patient-Centered Real-World Evidence in Rare Diseases

Pharma can target ultra-rare conditions ‚Äî the next step is financing them

Advancing identity data management for digital engagement: How leading organizations are doing it

Keeping up with demands for healthcare outside of the hospital: Critical ways tech supports the distributed care model

Driving value from healthcare data: How integrated cloud-based data is foundational to drive enterprise change

Closing the gaps of getting data to make decisions

The role of patient-centric technologies & tokenization in RWE studies

How Digital Health Can Empower Cancer Patients

Clinical Trial Innovation: How Healthcare Technology is Evolving

Connected communities: Advancing population health through data and emerging technology

Certified Corporate Wellness Specialist(CCWS): Is It For Me?

The reimagined hospital: How health systems are keeping up with new tech

L7|LIVE SF - Tuesday, June 13th, 2023

Transforming Healthcare Using Big Data and Remote Monitoring

Synthesise RWE and AI. Transform patient-driven healthcare

Endpoints at #DIA23

From Challenges to Opportunities: Navigating the EU MDR as a Medical Device Manufacturer

Ushering in the new era of payvider integration

Partnering with NHS in a crisis: The role for industry

Unlock the Power of Data Review & Collaboration: Maximizing Trial Success

HTA Implementation in the MEA Region - an Overview from WHO and Country Updates

Improving Treatment Access & Outcomes by Integrating Social Determinants of Health Data with Real-World Evidence

How to Supercharge Real World Evidence Generation in Phase IV Trials

HEOR Writing: The Ins and Outs of Value Communications

Webcast: Taking the Complexity Out of Leveraging Health Plan Price Transparency Data

FDA Patient-Focused Drug Development (PFDD) Guidance

Creating Digital Biomarkers with Real-World and Existing Data by Xtalks

Beyond the payment variance report: How to resolve common, costly underpayment issues

Webcast: Strategies to Simplify Insurance Discovery

Looking Beyond Survival Data: Understanding the Value of Non-OS Endpoints in Oncology Reimbursement Decision-Making

Measuring the intangible- what is the true value of a "patient centric" initiative

Champion a seamless end-to-end insight generation process

Different HTA Perspectives on Reliably Estimating Treatment Effects

The Biotech landscape: Market trends, priorities, predictions, and pathways to FDA approval

Fit for Local Context? Establishing or Improving Deliberative Processes for HTA

Evidence Matters 2022

US Drug Pricing Reform: Potential impact on Pharma HEOR Evidence Generation - September 8th

When the Barrier to a Breakthrough Drug is You Can't Make It - September 28th

Cell & Gene Day 2022 | Virtual Event | August 24th

Biology's modern LIMS for labs of the future - August 17 | 12:00 pm - 1:00 pm EDT

Confronting care inequities in hospital medicine - August 18th, 2022

Pain R&D: Plenty of pain to go around, but who's making gains?

AI and Machine Learning Technologies: The New Normal of the Pharmaceutical Industry - July 27th

Digital Transformation to Support Operational, Therapeutic and Clinical Decision Making

Selecting Rapid Review Methods for Health Technology Assessment

Predicting Payer Uptake with Precision

It's Not FAIR! Improving Data Publishing Practices in Research-Interoperability

Exploring Best Practices and Innovation in New Registry Handbook: Part 2 - Understanding Quality

Rise of the Robots 2.0: Real Talk About Artificial Intelligence In Systematic Reviews

Informational Webinar & Alumni Panel: Online MS Degree, Pharm Outcomes & Policy

Patient-Centric RWE Research & Remote Monitored Care: Learnings from a support program leveraging telehealth & connected devices

Partnering with Disease Registries: The Value and Impact for Real-World Evidence Generation

Minimizing the Impact of Cross-Cultural Differences in COA Translations

What Every Researcher Needs to Know About Using Medicare Data for Real World Evidence

Medicare Part D: Price Negotiation Panel Discussion

Finding Value in Linking Real-World Data with Social Determinants of Health

Health Economic and Outcome Research (HEOR) for Medical Technologies for the US Healthcare Systems

Streamlining Health Technology Assessments by Automating Literature Reviews

Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access